🚀 VC round data is live in beta, check it out!

NanoEcho Valuation Multiples

Discover revenue and EBITDA valuation multiples for NanoEcho and similar public comparables like Epigenomics, Attana, Lumito, Level Bio and more.

NanoEcho Overview

About NanoEcho

NanoEcho AB (publ) is a Swedish medical technology company. The company is developing a new diagnostic method to track rectal cancer's effect on nearby lymph nodes for the generation of health economic gains. The company's imaging technology is based on a new medical method where nanotechnology is combined with modern ultrasound technology to improve diagnosis methods.


Founded

2019

HQ

Sweden

Employees

N/A

Financials (FY)

Revenue: $53K
EBITDA: ($2M)

EV

$765K

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

NanoEcho Financials

NanoEcho reported last fiscal year revenue of $53K and negative EBITDA of ($2M).

In the same fiscal year, NanoEcho generated $53K in gross profit, ($2M) in EBITDA losses, and had net loss of ($2M).


NanoEcho P&L

In the most recent fiscal year, NanoEcho reported revenue of $53K and EBITDA of ($2M).

NanoEcho expects next 12-month revenue of XXX and NTM EBITDA of XXX

See NanoEcho forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
RevenueXXX$53KXXXXXXXXX
Gross ProfitXXX$53KXXXXXXXXX
Gross MarginXXX100%XXXXXXXXX
EBITDAXXX($2M)XXXXXXXXX
EBITDA MarginXXX(2975%)XXXXXXXXX
EBIT MarginXXX(3137%)XXXXXXXXX
Net ProfitXXX($2M)XXXXXXXXX
Net MarginXXX(3208%)XXXXXXXXX

Financial data powered by Morningstar, Inc.

NanoEcho Stock Performance

NanoEcho has current market cap of $997K, and enterprise value of $765K.

Market Cap Evolution


NanoEcho's stock price is $0.00.

See NanoEcho trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$765K$997K0.3%XXXXXXXXX$-0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

NanoEcho Valuation Multiples

NanoEcho trades at 14.4x EV/Revenue multiple, and (0.5x) EV/EBITDA.

See valuation multiples for NanoEcho and 15K+ public comps

NanoEcho Financial Valuation Multiples

As of April 19, 2026, NanoEcho has market cap of $997K and EV of $765K.

Equity research analysts estimate NanoEcho's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

NanoEcho has a P/E ratio of (0.6x).

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$997KXXX$997KXXXXXXXXX
EV (current)$765KXXX$765KXXXXXXXXX
EV/RevenueXXX14.4xXXXXXXXXX
EV/EBITDAXXX(0.5x)XXXXXXXXX
EV/EBITXXX(0.5x)XXXXXXXXX
EV/Gross ProfitXXX14.4xXXXXXXXXX
P/EXXX(0.6x)XXXXXXXXX
EV/FCFXXX(0.4x)XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified NanoEcho Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

NanoEcho Margins & Growth Rates

NanoEcho's revenue in the last fiscal year grew by .

See operational valuation multiples for NanoEcho and other 15K+ public comps

NanoEcho Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
EBITDA MarginXXX(2975%)XXXXXXXXX
EBITDA GrowthXXX(4%)XXXXXXXXX
Opex to RevenueXXX3237%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

NanoEcho Public Comps

See public comps and valuation multiples for other Medical Imaging & Diagnostics comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
NanoEchoXXXXXXXXXXXXXXXXXX
EpigenomicsXXXXXXXXXXXXXXXXXX
AttanaXXXXXXXXXXXXXXXXXX
LumitoXXXXXXXXXXXXXXXXXX
Level BioXXXXXXXXXXXXXXXXXX
Elite DiagnosticXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

NanoEcho M&A Activity

NanoEcho acquired XXX companies to date.

Last acquisition by NanoEcho was on XXXXXXXX, XXXXX. NanoEcho acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by NanoEcho

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

NanoEcho Investment Activity

NanoEcho invested in XXX companies to date.

NanoEcho made its latest investment on XXXXXXXX, XXXXX. NanoEcho invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by NanoEcho

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About NanoEcho

When was NanoEcho founded?NanoEcho was founded in 2019.
Where is NanoEcho headquartered?NanoEcho is headquartered in Sweden.
Is NanoEcho publicly listed?Yes, NanoEcho is a public company listed on Nasdaq Stockholm.
What is the stock symbol of NanoEcho?NanoEcho trades under NANECH ticker.
When did NanoEcho go public?NanoEcho went public in 2024.
Who are competitors of NanoEcho?NanoEcho main competitors are Epigenomics, Attana, Lumito, Level Bio.
What is the current market cap of NanoEcho?NanoEcho's current market cap is $997K.
What is the current revenue of NanoEcho?NanoEcho's last fiscal year revenue is $53K.
What is the current EV/Revenue multiple of NanoEcho?Current revenue multiple of NanoEcho is 14.4x.
Is NanoEcho profitable?No, NanoEcho is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial